Testing effectiveness (Phase 2)Study completedNCT02228096
What this trial is testing
Study of Efficacy and Safety of CTL019 in Pediatric ALL Patients
Who this might be right for
B-cell Acute Lymphoblastic LeukemiaRelapsed B-cell Acute Lymphoblastic LeukemiaRefractory B-cell Acute Lymphoblastic Leukemia
Novartis Pharmaceuticals 75